Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells - PubMed (original) (raw)

. 1993 Feb 15;150(4):1446-57.

Affiliations

PMID: 8432987

Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells

S P Nickell et al. J Immunol. 1993.

Abstract

Recent in vivo depletion studies in mice demonstrated that CD8+ T cells play a critical role in acute resistance to experimental Trypanosoma cruzi infections. As part of efforts to characterize these protective CD8+ T cell effector populations, we report here that splenic lymphocytes from mice chronically infected with T. cruzi can be induced to express high levels of cytolytic activity after stimulation in vitro with irradiated T. cruzi-infected macrophages. Cytolytic activity can either be detected using a nonspecific lectin-dependent 51Cr-release assay or using 51Cr-labeled T. cruzi-infected target cells. Fresh splenocytes from chronically infected mice stimulated with T. cruzi-infected macrophages exhibit relatively "promiscuous" killing activity inasmuch as significant lysis of both T. cruzi-infected and uninfected syngeneic and allogeneic cells is detected. However, subsequent rounds of in vitro stimulation lead to the expression of lytic activity that is T. cruzi Ag-specific and MHC-restricted. Several short term in vitro maintained cytolytic T cell lines were shown to have mixed phenotypes by FACS analysis; approximately 50% to 75% of the cells in these populations were CD4-, CD8+, whereas 20% to 40% were CD4-, CD8-. Experiments in which effector cells were positively selected by adherence to anti-CD8 mAb-treated plates confirmed that CD8+ T cell could exhibit Ag-specific cytolytic activity against T. cruzi-infected target cells. Efforts are under way to clone these CTL to test their in vivo function and to determine their Ag specificity.

PubMed Disclaimer

Cited by

Axl receptor induces efferocytosis, dampens M1 macrophage responses and promotes heart pathology in Trypanosoma cruzi infection.
Rigoni TS, Vellozo NS, Guimarães-Pinto K, Cabral-Piccin M, Fabiano-Coelho L, Matos-Silva TC, Filardy AA, Takiya CM, Lopes MF. Rigoni TS, et al. Commun Biol. 2022 Dec 29;5(1):1421. doi: 10.1038/s42003-022-04401-w. Commun Biol. 2022. PMID: 36581764 Free PMC article.
Down Modulation of Host Immune Response by Amino Acid Repeats Present in a Trypanosoma cruzi Ribosomal Antigen.
Toro Acevedo CA, Valente BM, Burle-Caldas GA, Galvão-Filho B, Santiago HDC, Esteves Arantes RM, Junqueira C, Gazzinelli RT, Roffê E, Teixeira SMR. Toro Acevedo CA, et al. Front Microbiol. 2017 Nov 10;8:2188. doi: 10.3389/fmicb.2017.02188. eCollection 2017. Front Microbiol. 2017. PMID: 29176965 Free PMC article.
Apoptotic CD8 T-lymphocytes disable macrophage-mediated immunity to Trypanosoma cruzi infection.
Cabral-Piccin MP, Guillermo LV, Vellozo NS, Filardy AA, Pereira-Marques ST, Rigoni TS, Pereira-Manfro WF, DosReis GA, Lopes MF. Cabral-Piccin MP, et al. Cell Death Dis. 2016 May 19;7(5):e2232. doi: 10.1038/cddis.2016.135. Cell Death Dis. 2016. PMID: 27195678 Free PMC article.
Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells.
Camargo R, Faria LO, Kloss A, Favali CB, Kuckelkorn U, Kloetzel PM, de Sá CM, Lima BD. Camargo R, et al. PLoS One. 2014 Apr 21;9(4):e95977. doi: 10.1371/journal.pone.0095977. eCollection 2014. PLoS One. 2014. PMID: 24752321 Free PMC article.
Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.
Dwivedi V, Khan A, Vasco A, Fatima N, Soni VK, Dangi A, Misra-Bhattacharya S, Owais M. Dwivedi V, et al. Pharm Res. 2008 Oct;25(10):2312-9. doi: 10.1007/s11095-008-9631-2. Epub 2008 Jun 13. Pharm Res. 2008. PMID: 18551251

Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells - PubMed (original) (raw)